Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GCM1 | hg38_v1_chr6_-_53148822_53148846 | 0.22 | 2.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22409755 Show fit | 9.76 |
ENST00000390299.2
|
immunoglobulin lambda variable 1-40 |
|
chr22_+_22758698 Show fit | 8.50 |
ENST00000390312.2
|
immunoglobulin lambda variable 2-14 |
|
chr22_+_22195753 Show fit | 8.23 |
ENST00000390285.4
|
immunoglobulin lambda variable 6-57 |
|
chr22_+_22380766 Show fit | 8.22 |
ENST00000390297.3
|
immunoglobulin lambda variable 1-44 |
|
chr22_+_22822658 Show fit | 7.80 |
ENST00000620395.2
|
immunoglobulin lambda variable 2-8 |
|
chr22_+_22322452 Show fit | 7.72 |
ENST00000390290.3
|
immunoglobulin lambda variable 1-51 |
|
chr22_+_22792485 Show fit | 7.67 |
ENST00000390314.2
|
immunoglobulin lambda variable 2-11 |
|
chr22_+_22811737 Show fit | 7.43 |
ENST00000390315.3
|
immunoglobulin lambda variable 3-10 |
|
chr2_-_89330429 Show fit | 7.16 |
ENST00000620613.1
|
immunoglobulin kappa variable 2-40 |
|
chr22_+_22327298 Show fit | 6.50 |
ENST00000390291.2
|
immunoglobulin lambda variable 1-50 (non-functional) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 78.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 49.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 11.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 7.1 | GO:0002250 | adaptive immune response(GO:0002250) |
1.3 | 6.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.5 | 5.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 5.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 4.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 4.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 3.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 74.0 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 52.0 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 11.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 7.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 6.5 | GO:0032587 | ruffle membrane(GO:0032587) |
2.1 | 6.3 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.1 | 5.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 5.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 3.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 3.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 122.2 | GO:0003823 | antigen binding(GO:0003823) |
0.9 | 11.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 11.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 6.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
1.3 | 6.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.2 | 6.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 5.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 5.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 5.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 4.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 6.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 6.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 4.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 4.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 6.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.9 | 5.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 3.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 3.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |